Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.80 per share. The dividend will be paid on October 20, 2025, to shareholders who hold Quest Diagnostics common stock as of the record date of October 3, 2025.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, DGX declined 0.34%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302529498.html
SOURCE Quest Diagnostics